 |
|
|
| |
Clinical outcomes of once-daily darunavir in treatment-experienced patients with
darunavir resistance associated mutations through 48 weeks of treatment
|
| |
| |
IDWeek, October 2-6, 2019, Washington, DC
Reported by Jules Levin
Charlotte-Paige Rolle MD MPH1, 2; Omar Marquez LPN CRC1;Vu Nguyen MS3; Federico HinestrosaMD1,3; Edwin DeJesusMD1,3
1Orlando Immunology Center, Orlando, FL, USA, 2 Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA, 3University of Central Florida College of Medicine, Orlando, FL, USA
|
| |
|
|
|
|
|
